A study led by biomedical scientists at the University of California, Riverside, has shown for the first time that a father’s ...

Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

Human immunodeficiency virus (HIV) infections are still fairly common and an estimated 40 million people worldwide are ...

PYC Therapeutics Limited ( ($AU:PYC) ) has shared an announcement. PYC Therapeutics has issued 2,000,000 unlisted options to director Peter ...

A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of virologic ...

TheFly reported on December  16 that Oppenheimer raised its price target on WVE to $32 from $24 while maintaining an ...

Researchers identified a previously unknown placental molecular process disrupted by gestational diabetes, helping explain ...

As the Arctic warms and sea ice disappears, polar bears are being pushed into conditions they have never faced before. Their ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

An ancient asteroid older than Earth itself has reignited debate over whether life began in space. NASA's Bennu discovery ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...